Wilson P W, Myers R H, Larson M G, Ordovas J M, Wolf P A, Schaefer E J
Framingham Heart Study, MA 01701.
JAMA. 1994 Dec 7;272(21):1666-71.
To describe the association between apolipoprotein E alleles (epsilon 2, epsilon 3, and epsilon 4), dyslipidemias, and coronary heart disease (CHD).
Cross-sectional prevalence study.
Community-based sample of men (n = 1034) and women (n = 916) aged 40 to 77 years who are participating in a long-term study of cardiovascular disease. Study participants underwent fasting lipid measurements, coronary risk factor determinations, and a comprehensive evaluation for the presence of current or previous CHD.
Compared with the epsilon 3 allele, the epsilon 4 allele was associated with elevated low-density lipoprotein cholesterol values (> or = 4.14 mmol/L [160 mg/dL]) in women, the epsilon 2 and epsilon 4 alleles were associated with moderately elevated triglyceride values (> or = 2.82 mmol/L [250 mg/dL]) in men, and the epsilon 2 allele was associated with severely elevated triglyceride values (> or = 5.64 mmol/L [500 mg/dL]) in men. The apolipoprotein E alleles were not associated with hypertension, obesity, smoking, or diabetes, but the epsilon 4 allele frequency was reduced in women after 60 years of age. The age-adjusted prevalence of CHD was associated with the epsilon 4 allele in both men (relative odds = 1.53, P = .04) and women (relative odds = 1.99, P = .05). In analyses for women and for both sexes combined, this relation persisted after adjustment by hypertension, smoking, obesity, diabetes, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol.
Apolipoprotein E alleles are important genetic markers for dyslipidemia and CHD. The estimated CHD odds associated with the epsilon 4 allele appears to be greater than that for any other known genetic lipid abnormality, and the association of the epsilon 4 allele with CHD remains significant in women and both sexes combined after adjustment by traditional coronary risk factors and lipids.
描述载脂蛋白E等位基因(ε2、ε3和ε4)、血脂异常与冠心病(CHD)之间的关联。
横断面患病率研究。
以社区为基础,选取年龄在40至77岁之间的男性(n = 1034)和女性(n = 916)作为样本,他们参与了一项心血管疾病的长期研究。研究参与者接受了空腹血脂测量、冠心病危险因素测定以及对当前或既往冠心病存在情况的全面评估。
与ε3等位基因相比,ε4等位基因与女性低密度脂蛋白胆固醇值升高(≥4.14 mmol/L [160 mg/dL])相关,ε2和ε4等位基因与男性甘油三酯值中度升高(≥2.82 mmol/L [250 mg/dL])相关,而ε2等位基因与男性甘油三酯值重度升高(≥5.64 mmol/L [500 mg/dL])相关。载脂蛋白E等位基因与高血压、肥胖、吸烟或糖尿病无关,但60岁以后女性中ε4等位基因频率降低。经年龄调整后的冠心病患病率在男性(相对比值 = 1.53,P = 0.04)和女性(相对比值 = 1.99,P = 0.05)中均与ε4等位基因相关。在对女性以及男女合并的分析中,在经高血压、吸烟、肥胖、糖尿病、高密度脂蛋白胆固醇和低密度脂蛋白胆固醇调整后,这种关系仍然存在。
载脂蛋白E等位基因是血脂异常和冠心病的重要遗传标志物。与ε4等位基因相关的估计冠心病比值似乎大于任何其他已知的遗传性脂质异常,并且在经传统冠心病危险因素和血脂调整后,ε4等位基因与冠心病的关联在女性以及男女合并中仍然显著。